Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan

2 years ago Posted By : User Ref No: WURUR89953 0
  • Image
  • TypeSeminar
  • Image
  • Location Online Event
  • Price
  • Date 02-12-2021
Seminar Title
Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan
Event Type
Seminar
Seminar Date
02-12-2021
Location
Online Event
Organization Name / Organize By
Complianceonline
Organizing/Related Departments
Sales & marketing
Organization Type
Event Management Company
SeminarCategory
Both (Technical & Non Technical)
SeminarLevel
All (State/Province/Region, National & International)
Related Industries

Business Development

Administration/Management

Manufacturing

Medical/Healthcare/Hospital

Location
Online Event

Global Medical Device Regulations continue to evolve, as devices become more diverse and sophisticated. Understanding the regulations and requirements in your targeted markets will expedite speed-to-market of innovative products and assist patients needing access to life-saving products and technologies. Government Regulatory Authorities, needing to become more efficient with their time, are looking for ways to better use their internal resources without compromising safety in products, which become marketable. One such example is the Medical Device Single Audit Program [MDSAP], where Authorized Organizations would be allowed to carry out a single GMP audit on medical device manufacturing facilities and have it stand to support registrations across the current participating member countries: U.S. Canada, Brazil, Australia and Japan. Health Canada has now made the MDSAP process mandatory for all licensed products in Canada.

Registration Fees
Not Mention
Registration Ways
Email
Website
Address/Venue
Virtual Seminar  Virtual Seminar,6201 America Center Drive Suite 240, San Jose, CA 95002, USA 
Contact